Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study

Xia Shi-jun; Du Xin; Li Chao; Wu Jia-hui; Tang Ri-bo; Chang San-shuai; Guo Xue-yuan; Yu Rong-hui; Long De-yong; Bai Rong; Liu Nian; Sang Cai-hua; Li Song-nan; Liu Xiao-hui; Pan Jian-hong; Dong Jian-zeng; Lip Gregory Y. H.; Ma Chang-sheng

首页> 外文期刊>International Journal of Cardiology >Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study

【24h】

Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study

机译：对我国心房颤动患者的基于循证的他汀类药物治疗：CAFR（中国心房颤动登记处）研究报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Atrial fibrillation (AF) is associated with increased incidence of cardiovascular disease, and hence, statin therapy is indicated in majority of AF patients.

机译：背景：心房颤动（AF）与心血管疾病的发生率增加有关，因此，大多数AF患者表明他汀类药物治疗。

著录项

来源
《International Journal of Cardiology》 |2016年第null期|共6页
作者
Xia Shi-jun; Du Xin; Li Chao; Wu Jia-hui; Tang Ri-bo; Chang San-shuai; Guo Xue-yuan; Yu Rong-hui; Long De-yong; Bai Rong; Liu Nian; Sang Cai-hua; Li Song-nan; Liu Xiao-hui; Pan Jian-hong; Dong Jian-zeng; Lip Gregory Y. H.; Ma Chang-sheng;
展开▼
作者单位

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Peking Univ Clin Res Inst Beijing Peoples R China;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

Univ Birmingham City Hosp Ctr Cardiovasc Sci Birmingham W Midlands England;

Capital Med Univ Beijing Anzhen Hosp Natl Clin Res Ctr Cardiovasc Dis Dept Cardiol Beijing;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Atrial fibrillation; Evidence-based statin therapy; China;

机译：心房颤动;基于证据的他汀类药物治疗;中国;

相似文献

外文文献
中文文献
专利

1. Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study [J] . Xia Shi-jun, Du Xin, Li Chao, International Journal of Cardiology . 2016,第Null期

机译：对我国心房颤动患者的基于循证的他汀类药物治疗：CAFR（中国心房颤动登记处）研究报告
2. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study [J] . Jiang Chao, Lan Di‐Hui, Du Xin, Journal of cardiovascular electrophysiology . 2019,第12期

机译：心房颤动患者可修正危险因素与中风和死亡关系的患病率：中国心房颤动注册研究的报告
3. Contemporary characteristics, management, and outcomes of patients hospitalized for atrial fibrillation in China: results from the real-world study of Chinese atrial fibrillation registry [J] . Qing-Yan Zhao, Xi Wang, Shu Zhang, 中华医学杂志（英文版） . 2020,第023期

机译：中国心房颤动住院患者的当代特征，管理和结果：中国心房颤动注册管理机构的真实研究结果
4. Risk Factors for Stroke in Chinese with Atrial Fibrillation: Case-control Study [C] . O.Y. Hu, Y.H. Sun, Z.Q. Zhou, World Congress on Cardiac Pacing and Electrophysiology . 2003

机译：心房颤动中文中风危险因素：案例控制研究
5. Cardiac ablation as the initial therapy for symptomatic atrial fibrillation results in less recurrance of atrial fibrillation when compared to antiarrhythmic therapy [D] . Mikhli, Erica 2011

机译：与抗心律失常治疗相比，心脏消融作为症状性心房颤动的初始治疗导致心房颤动的较少复发
6. Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry [O] . Hai-Feng Liang, Xin Du, Ying-Chun Zhou, 2019

机译：华法林治疗房颤患者抗凝治疗的控制：来自中国房颤注册中心的研究
7. Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry [O] . Hai-Feng Liang, Xin Du, Ying-Chun Zhou, 2019

机译：用华法林治疗心房颤动患者抗凝治疗的控制：中国心房颤动登记处的研究

Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study

摘要

著录项

相似文献

相关主题

期刊订阅